539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Performance
- Low
- ₹1,807
- High
- ₹1,877
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,877
- Open Price₹1,850
- Previous Close₹1,788
- Volume15,829
Investment Returns
- Over 1 Month + 25.15%
- Over 3 Month + 79.29%
- Over 6 Month + 171.32%
- Over 1 Year + 176.92%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 30.7
- PEG Ratio
- 0.5
- Market Cap Cr
- 887
- P/B Ratio
- 6.8
- Average True Range
- 83.97
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 74.81
- RSI
- 76.06
- MFI
- 59.72
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,877.40
+
89.4
(5%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,638.62
- 50 Day
- ₹1,476.90
- 100 Day
- ₹1,286.63
- 200 Day
- ₹1,092.94
Resistance and Support
1853.93
- R3 1,971.27
- R2 1,924.33
- R1 1,900.87
- S1 1,830.47
- S2 1,783.53
- S3 1,760.07
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend | |
| 2025-02-04 | Quarterly Results |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,877 As on 18 November, 2025 | 02:43
The Market Cap of Fredun Pharmaceuticals is ₹886.5 Cr As on 18 November, 2025 | 02:43
The P/E ratio of Fredun Pharmaceuticals is 30.7 As on 18 November, 2025 | 02:43
The PB ratio of Fredun Pharmaceuticals is 6.8 As on 18 November, 2025 | 02:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.